Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02252042 |
|---|---|
| Brief Title: | Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040) |
| First Submitted : | September 25, 2014 |
| First Submitted that Met QC Criteria : | September 25, 2014 |
| First Posted : | September 29, 2014 (Estimate) |
| Results First Submitted : | May 4, 2018 |
| Results First Submitted that Met QC Criteria : | August 10, 2018 |
| Results First Posted : | August 13, 2018 |
| Last Update Submitted that Met QC Criteria : | August 24, 2022 |
| Last Update Posted : | September 13, 2022 |